Arunima Sengupta
Papers
1
Total Citations
14
H-Index
1
About
Arunima Sengupta is pioneering the frontier of lung-on-chip technology, with a focused expertise in developing advanced in vitro models that replicate human respiratory responses to environmental toxins and cigarette smoke. Her landmark work introduces a next-generation system that integrates a breathing lung-on-chip with smoke inhalation capabilities, offering a transformative alternative to animal models for studying chronic obstructive pulmonary disease (COPD) and lung cancer. This innovative platform, which has already garnered 14 citations since its 2025 publication, allows for continuous, physiologically relevant exposure to cigarette smoke, capturing the nuanced cellular and molecular changes that drive disease progression. By bridging the gap between traditional cell culture and human physiology, Sengupta’s contributions are reshaping how researchers investigate smoke-induced lung pathologies and test potential therapeutics. Her work stands out for its translational potential, directly addressing the limitations of animal models and providing a more ethical, accurate, and high-throughput system for studying respiratory diseases. As a rising leader in organ-on-a-chip engineering, Sengupta is driving a paradigm shift toward personalized, human-relevant disease modeling.
Research Focus
Key Achievements
Top Papers
- 1